Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mebendazole and related anthelmintics.

× No keyword cloud information.

10 in total

1. Fasciola hepatica: localization and partial characterization of tubulin.

Authors: A W Stitt; I Fairweather; A G Trudgett; C F Johnston
Journal: Parasitol Res Date: 1992 Impact factor: 2.289

2. Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.

Authors: Sangram S Kale; Ganesh S Jedhe; Sachin N Meshram; Manas K Santra; Ernest Hamel; Gangadhar J Sanjayan
Journal: Bioorg Med Chem Lett Date: 2015-03-14 Impact factor: 2.823

Review 3. Clinical pharmacokinetics of anthelmintic drugs.

Authors: G Edwards; A M Breckenridge
Journal: Clin Pharmacokinet Date: 1988-08 Impact factor: 6.447

4. In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.

Authors: S K Katiyar; T D Edlind
Journal: Antimicrob Agents Chemother Date: 1997-12 Impact factor: 5.191

5. In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.

Authors: M C Cruz; M S Bartlett; T D Edlind
Journal: Antimicrob Agents Chemother Date: 1994-02 Impact factor: 5.191

6. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors: A W Stitt; I Fairweather
Journal: Parasitol Res Date: 1993 Impact factor: 2.289

Mebendazole and related anthelmintics.

1. Fasciola hepatica: localization and partial characterization of tubulin.

2. Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.

Review 3. Clinical pharmacokinetics of anthelmintic drugs.

4. In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.

5. In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.

6. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

7. Effects of multiple doses of isoprinosine on Echinococcus multilocularis metacestodes.

8. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence.

9. Cytotoxicity of mebendazole against established cell lines from the human, rat, and mouse liver.

10. UMF-078: A modified flubendazole with potent macrofilaricidal activity against Onchocerca ochengi in African cattle.